SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053592
Filing Date
2020-11-12
Accepted
2020-11-12 16:21:51
Documents
62
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktx-10q_20200930.htm 10-Q 2193541
2 EX-10.6 nktx-ex106_29.htm EX-10.6 18197
3 EX-31.1 nktx-ex311_6.htm EX-31.1 18604
4 EX-31.2 nktx-ex312_8.htm EX-31.2 17932
5 EX-32 nktx-ex321_7.htm EX-32.1 14929
  Complete submission text file 0001564590-20-053592.txt   7403760

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nktx-20200930.xml EX-101.INS 1509968
7 XBRL TAXONOMY EXTENSION SCHEMA nktx-20200930.xsd EX-101.SCH 50844
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktx-20200930_cal.xml EX-101.CAL 55371
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktx-20200930_def.xml EX-101.DEF 182685
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktx-20200930_lab.xml EX-101.LAB 417797
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktx-20200930_pre.xml EX-101.PRE 326020
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 650-215-0385
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39370 | Film No.: 201307053
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences